Matinas BioPharma Holdings, Inc. (MTNB): Depreciation & Amortization
$32.0K
Year ended 2025-12-31
$2.0K
Trailing 12 months to 2026-06-30
-54.4%
3-year compound annual growth
-32.7%
5-year compound annual growth
-3.0%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $32.0K | -91.2% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $365.0K | -5.2% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $385.0K | +14.2% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $337.0K | +38.1% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $244.0K | +5.6% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $231.1K | +12.2% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $206.0K | -5.7% | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | $218.3K | +117.0% | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | $100.6K | +91.1% | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $52.6K | +21.0% | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | $43.5K | +4.6% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $41.6K | n/a | 2016-03-30, From 2014-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $32.0K | -91.2% |
| Cannapharmarx, Inc. (CPMD) | 2024-12-31 | $0 | -100.0% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $192.0K | -42.5% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $73.0K | -62.4% |
| OS Therapies Inc (OSTX) | 2025-12-31 | $363.1K | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $12.0K | -30.9% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $68.8K | -27.9% |
| Lunai Bioworks Inc. (LNAI) | 2025-06-30 | $129.1K | +5.9% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $618.0K | -3.0% |
Compare MTNB, CPMD, CVSI, SER side by side · Screen every company in Pharmaceutical Preparations ↗